Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats - PubMed (original) (raw)
Comparative Study
. 1989 Nov;125(5):2454-62.
doi: 10.1210/endo-125-5-2454.
Affiliations
- PMID: 2551653
- DOI: 10.1210/endo-125-5-2454
Comparative Study
Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats
D G Hurrell et al. Endocrinology. 1989 Nov.
Abstract
Obesity is associated with insulin resistance and type II diabetes mellitus. In the present study, we have characterized hepatic insulin receptor function in two animal models of obesity: the Zucker fatty rat (ZFR), a model of genetic obesity with severe hyperinsulinemia, and the Sprague-Dawley rat with dietary obesity, a model of acquired obesity. Zucker fatty rats were also treated with streptozotocin (STZ) in an effort to examine the effects of relative insulin deficiency and hyperglycemia in the setting of obesity. Using wheat germ agglutinin-purified insulin receptor extracted from liver, no significant difference in insulin binding was identified in either model of obesity. beta-Subunit autophosphorylation was significantly decreased in both obese models relative to that in controls (72% in the obese ZFR and 49% in the overfed Sprague-Dawley model). Kinase activity, as measured by phosphorylation of the 1142-1153 synthetic peptide, was also decreased in both models of obesity by 22% and 64%, respectively. In the Zucker rat, STZ treatment led to an 80% increase in receptor concentration and a further 70% increase in beta-subunit autophosphorylation per receptor, whereas tyrosine kinase activity toward substrate was not altered. Since kinase activity is closely linked to autophosphorylation, we determined the fraction of autophosphorylated (activated) receptors vs. non-phosphorylated (inactive) receptors by using antiphosphotyrosine antibody to precipitate receptors bound with [125I]insulin. There was no significant difference in the percentage of activated insulin receptors in the dietary obese, ZFR, or STZ-treated Zucker rat vs. that in the controls. In all models, the percentage of activated receptors ranged from 32-46% of the total receptor pool. These data suggest that in genetic and acquired obesity, autophosphorylation of the beta-subunit is reduced and is a limiting factor in insulin receptor activation. A similar fraction of all receptors appears to undergo some level of autophosphorylation; however, full autophosphorylation and, thus, activation of the receptor do not occur, and this results in a decrease in kinase activity. This block in autophosphorylation may account for significant reductions in insulin receptor kinase function in obesity.
Similar articles
- Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats.
Slieker LJ, Roberts EF, Shaw WN, Johnson WT. Slieker LJ, et al. Diabetes. 1990 May;39(5):619-25. doi: 10.2337/diab.39.5.619. Diabetes. 1990. PMID: 2332119 - Diabetes-associated impairment of hepatic insulin receptor tyrosine kinase activity: a study of mechanisms.
Block NE, Komori K, Robinson KA, Dutton SL, Lam CF, Buse MG. Block NE, et al. Endocrinology. 1991 Jan;128(1):312-22. doi: 10.1210/endo-128-1-312. Endocrinology. 1991. PMID: 1846101 - Dephosphorylation of the insulin receptor partially restores the decreased autophosphorylation in streptozotocin induced diabetic rats.
Iwama N, Watarai T, Kajimoto Y, Yamasaki Y, Yokoyama T, Kawamori R, Kamada T. Iwama N, et al. Diabetes Res. 1991 May;17(1):25-32. Diabetes Res. 1991. PMID: 1816977 - The subunit structure of the insulin receptor and molecular interactions with major histocompatibility complex antigens.
Fehlmann M, Chvatchko Y, Brandenburg D, Van Obberghen E, Brossette N. Fehlmann M, et al. Biochimie. 1985 Oct-Nov;67(10-11):1155-9. doi: 10.1016/s0300-9084(85)80114-0. Biochimie. 1985. PMID: 2416352 Review. - Insulin receptors in the mammalian central nervous system: binding characteristics and subunit structure.
Gammeltoft S, Fehlmann M, Van Obberghen E. Gammeltoft S, et al. Biochimie. 1985 Oct-Nov;67(10-11):1147-53. doi: 10.1016/s0300-9084(85)80113-9. Biochimie. 1985. PMID: 3907719 Review.
Cited by
- Reduced Tyrosine and Serine-632 Phosphorylation of Insulin Receptor Substrate-1 in the Gastrocnemius Muscle of Obese Zucker Rat.
Ola MS. Ola MS. Curr Issues Mol Biol. 2022 Nov 29;44(12):6015-6027. doi: 10.3390/cimb44120410. Curr Issues Mol Biol. 2022. PMID: 36547071 Free PMC article. - Pathogenesis of selective insulin resistance in isolated hepatocytes.
Cook JR, Langlet F, Kido Y, Accili D. Cook JR, et al. J Biol Chem. 2015 May 29;290(22):13972-80. doi: 10.1074/jbc.M115.638197. Epub 2015 Apr 14. J Biol Chem. 2015. PMID: 25873396 Free PMC article. - Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats.
Chen W, Chen Z, Xue N, Zheng Z, Li S, Wang L. Chen W, et al. Naunyn Schmiedebergs Arch Pharmacol. 2013 Aug;386(8):721-32. doi: 10.1007/s00210-013-0875-y. Epub 2013 Apr 26. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23620336 - Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.
Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL. Jiang ZY, et al. J Clin Invest. 1999 Aug;104(4):447-57. doi: 10.1172/JCI5971. J Clin Invest. 1999. PMID: 10449437 Free PMC article. - Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.
Virkamäki A, Ueki K, Kahn CR. Virkamäki A, et al. J Clin Invest. 1999 Apr;103(7):931-43. doi: 10.1172/JCI6609. J Clin Invest. 1999. PMID: 10194465 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical